A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection-Reference-Cited by-同舟云学术

A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection

Published:2023-12 Issue:12 Volume:4 Page:101305
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Adams Lucas J.,VanBlargan Laura A.,Liu Zhuoming,Gilchuk Pavlo,Zhao Haiyan,Chen Rita E.,Raju Saravanan,Chong Zhenlu,Whitener Bradley M.,Shrihari Swathi,Jethva Prashant N.,Gross Michael L.,Crowe James E.,Whelan Sean P.J.,Diamond Michael S.,Fremont Daved H.^ORCID

Funder

AstraZeneca

University of Washington

National Institutes of Health

Center for Cellular Imaging, Washington University

Vir Biotechnology

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference99 articles.

1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine;Baden;N. Engl. J. Med.,2021

2. The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in Vitro and in Vivo activity against SARS-CoV-2;Cathcart;bioRxiv,2021

3. SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19;Chen;N. Engl. J. Med.,2021

4. Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine;Keech;N. Engl. J. Med.,2020

5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine;Polack;N. Engl. J. Med.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting;2024-01-04